Evaluation of antimicrobial susceptibility of Escherichia coli strains isolated in Rabat University Hospital (Morocco)

BMC Research Notes
Nabil AlemMostafa Elouennass

Abstract

Escherichia coli (E. coli) is the most commonly isolated bacteria in human pathology. In Morocco the data concerning the nature and the rates of antibiotic resistance of E. coli in both hospitals and city environment remains relatively poor and needs further investigations. During a 16 months period, E. coli isolates were collected from different culture specimens received in the Bacteriology Department of the Military teaching Hospital Mohammed-V-Rabat for routine diagnostic purposes. E. coli isolates were identified and their antimicrobial susceptibility pattern was determined. A total of 1369 E. coli isolates comprising 33% (1369/4110) of culture-positive samples were consecutively collected. Isolates of E. coli were, in 40.5% (554/1369) of cases from hospitalized patients and in 59.5% (815/1369) of cases from outpatients. Urine isolates represented 82% (1123/1369) of the cases. High rates of resistance were found for amoxicillin (42.5%), cefalotin (30.4%), norfoloxacin (29.9%) and sulfamethoxazole (37.7%). The detection rate of ESBL was 6.1% (85/1369). In hospitalized patients 11.9% of the isolates of E. coli (66/554) had an ESBL phenotype while in outpatients cases only 2.3% of isolates of E. coli (19/815) had this phenoty...Continue Reading

References

Dec 19, 2000·International Journal of Antimicrobial Agents·M Chomarat
Feb 18, 2003·JAMA : the Journal of the American Medical Association·Melinda M NeuhauserJohn P Quinn
Mar 5, 2003·The Journal of Antimicrobial Chemotherapy·Amani El KholyDavid L Longworth
Sep 9, 2006·FEMS Microbiology Letters·Susan M TurnerIan R Henderson
May 8, 2007·International Journal of Medical Microbiology : IJMM·Xiaolei YuTill T Bachmann
Jun 20, 2008·Annals of Clinical Microbiology and Antimicrobials·David C BeanDavid W Wareham
Feb 19, 2009·The Journal of Antimicrobial Chemotherapy·Jesús Rodríguez-BañoAlvaro Pascual
May 5, 2010·Journal of Infection in Developing Countries·Nasim KashefSahba Shahbazi
Dec 16, 2011·Journal of Infection in Developing Countries·Fatna BourjilatMohammed Timinouni
Dec 3, 2013·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Afonso Gomes AbreuAzizedite Guedes Gonçalves
May 28, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M C El BouamriS Zouhair
Oct 15, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M C El BouamriS Zouhair

❮ Previous
Next ❯

Citations

Jan 25, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Larbi Zakaria NabtiSylvain Godreuil
Sep 19, 2019·Biomédica : revista del Instituto Nacional de Salud·Verônica Dias GonçalvesJosé Augusto Adler Pereira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Abdulrahman Abdulla KaderSelvarayan Mahimai Dass
© 2021 Meta ULC. All rights reserved